Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gabriela S. Generette"'
Publikováno v:
IDCases, Vol 28, Iss , Pp e01511- (2022)
Since the onset of the COVID-19 pandemic, to date, around 385 million cases have been diagnosed worldwide leading to an estimated 5.7 million death toll. Mass vaccination campaigns have been conducted to control the spread of infection with the most
Externí odkaz:
https://doaj.org/article/6172144b9fab40b987a0edcd4b9caa86
Autor:
Piotr J. Bachul, Karolina Golab, Lindsay Basto, Steven Zangan, Jordan S. Pyda, Angelica Perez-Gutierrez, Peter Borek, Ling-Jia Wang, Martin Tibudan, Dong-Kha Tran, Roi Anteby, Gabriela S. Generette, Jędrzej Chrzanowski, Wojciech Fendler, Laurencia Perea, Kumar Jayant, Aaron Lucander, Celeste Thomas, Louis Philipson, J. Michael Millis, John Fung, Piotr Witkowski
Publikováno v:
Cell Transplantation, Vol 30 (2021)
A recent randomized, multicenter trial did not show benefit of a CXCR1/2 receptor inhibitor (Reparixin) when analysis included marginal islet mass (>3,000 IEQ/kg) for allotransplantation and when immunosuppression regimens were not standardized among
Externí odkaz:
https://doaj.org/article/ea2f1285dd134ef0ab79aab288bd503c
Autor:
Lindsay Basto, Roi Anteby, Laurencia Perea, Aaron Lucander, Celeste C. Thomas, Martin Tibudan, Gabriela S. Generette, Damian Grybowski, Karolina Golab, Piotr J. Bachul, John J. Fung, Ling Jia Wang, Jordan Pyda, Piotr Witkowski
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 12
Journal of Clinical Medicine, Vol 10, Iss 2708, p 2708 (2021)
Volume 10
Issue 12
Journal of Clinical Medicine, Vol 10, Iss 2708, p 2708 (2021)
(1) Background: The correlation between titers of islet autoantibodies (IAbs) and the loss of transplanted islets remains controversial. We sought to evaluate the prognostic utility of monitoring IAbs in diabetic patients after islet transplantation
Autor:
Lindsay Basto, Laurencia Perea, John J. Fung, Gabriela S. Generette, Piotr J. Bachul, Jordan Pyda, Martin Tibudan, Aaron Lucander, Roi Anteby, Angelica Perez-Gutierrez, Karolina Golab, Peter Borek, Piotr Witkowski
Publikováno v:
Diabetes. 70
Introduction: Prospective randomized multicenter trial did not find advantage of CXCR1/2 blocker (Reparixin) over placebo in islet transplantation in patients with type 1 diabetes mellitus and problematic hypoglycemia at 1 year follow-up. We note fav
Autor:
Piotr Witkowski, Angelica Perez-Gutierrez, Jayant Kumar, Laurencia Perea, Piotr J. Bachul, Louis H. Philipson, Gabriela S. Generette, Jordan Pyda, Karolina Golab, Peter Borek, Celeste C. Thomas, Lindsay Basto, Braden Juengel, Martin Tibudan, John J. Fung
Publikováno v:
Diabetes. 70
Introduction: Pre-vascularized Sernova Cell Pouch (SCP) device was developed to provide an optimal environment for cell/islet engraftment in the extravascular space. A first-in-human pilot study showed SCP safety/islet vascularization; however, condi
Publikováno v:
Journal of the American College of Cardiology. 79:3277
Autor:
Jeffrey B. Matthews, Katherine E. Boylan, Piotr Witkowski, Gabriela S. Generette, Jordan Pyda, John Hart, Piotr J. Bachul, Lindsay Yassan, John J. Fung
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 21(5)
In 2008 Westermark et al. postulated that amyloid depositions found in allotransplanted islets derived from either islet overstimulation due to insulin production (as in type 2 diabetes), toxicity of immunosuppression, or perhaps both.1 Amyloid depos
Autor:
Laurencia Perea, Piotr J. Bachul, Braden Juengel, Ling-Jia Wang, Celeste C. Thomas, Martin Tibudan, Gabriela S. Generette, Piotr Witkowski, Louis H. Philipson, Peter Borek, Jayant Kumar, Lindsay Basto, Angelica Perez-Gutierrez, John J. Fung, Karolina Golab
Publikováno v:
Transplantation. 105:S25-S25
Autor:
Roi Anteby, Angelica Perez-Gutierrez, Gabriela S. Generette, Ling-Jia Wang, Rolf N. Barth, John J. Fung, Piotr Witkowski, Martin Tibudan, Lindsay Basto, Piotr J. Bachul, Laurencia Perea, Karolina Golab, Peter Borek
Publikováno v:
Transplantation. 105:S3-S3
Autor:
Celeste C. Thomas, Louis H. Philipson, Dong-Kha V. Tran, Piotr Witkowski, Gabriela S. Generette, Martin Tibudan, J Michael Millis, Aaron Lucander, Peter Borek, Karolina Golab, Jędrzej Chrzanowski, Laurencia Perea, Ling-Jia Wang, Piotr J. Bachul, Roi Anteby, Steven Zangan, Jordan Pyda, Angelica Perez-Gutierrez, Wojciech Fendler, Kumar Jayant, Lindsay Basto, John J. Fung
Publikováno v:
Cell Transplantation, Vol 30 (2021)
Cell Transplantation
Cell Transplantation
A recent randomized, multicenter trial did not show benefit of a CXCR1/2 receptor inhibitor (Reparixin) when analysis included marginal islet mass (>3,000 IEQ/kg) for allotransplantation and when immunosuppression regimens were not standardized among